ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,665Medicare Part D Prescriptions Filled, Including Refills

Rank: 284 out of 1206

$581K Total Retail Price of All Prescriptions

Rank: 102 out of 1206

209 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 209 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 209 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,032 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
HYDROCODONE-ACETAMINOPHEN 287 229 S3 1 7
FUROSEMIDE 286 217 2 5
WARFARIN SODIUM 276 228 3 8
OMEPRAZOLE 263 229 4 3
AMLODIPINE BESYLATE 241 217 5 6
LISINOPRIL 232 185 6 4
LEVOTHYROXINE SODIUM 228 182 7 2
SIMVASTATIN 223 187 8 1
CITALOPRAM HBR 189 148 9 16
POTASSIUM CHLORIDE 171 156 10 12
METFORMIN HCL 150 116 11 10
LANTUS 131 88 12 38
CYMBALTA 123 94 13 63
DONEPEZIL HCL 120 120 14 29
GABAPENTIN 114 90 15 18
FAMOTIDINE 110 92 16 65
NAMENDA 107 104 17 36
SERTRALINE HCL 98 86 18 22
MIRTAZAPINE 92 80 19 50
METOPROLOL TARTRATE 90 90 20 9
ESCITALOPRAM OXALATE 88 77 21 86
CARVEDILOL 87 72 22 32
BACLOFEN 86 43 23 137
TAMSULOSIN HCL 84 80 24 26
TRAMADOL HCL 81 79 25 17
FENTANYL 79 75 S2 26 51
OXYCODONE HCL 79 41 S2 26 107
NYSTATIN 77 32 28 166
GENERLAC 71 55 29 300
OXYBUTYNIN CHLORIDE 69 42 30 68
BENZTROPINE MESYLATE 68 53 R 31 180
NOVOLOG 68 35 31 100
CLONIDINE HCL 67 28 33 88
METOPROLOL SUCCINATE 67 55 33 15
POLYETHYLENE GLYCOL 3350 67 59 33 31
GLIPIZIDE 63 63 36 64
QUETIAPINE FUMARATE 62 62 37 79
PREDNISONE 61 46 38 28
ISOSORBIDE MONONITRATE ER 60 60 39 40
CLOPIDOGREL 60 59 39 48
ALLOPURINOL 59 55 41 24
ATORVASTATIN CALCIUM 52 35 42 13
GLYBURIDE 51 42 R 43 69
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 43 44 82
BUMETANIDE 50 39 44 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.